Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients

Critical Care

Volumn 18, Issue 1, 2014, Pages

  Barletta, Jeffrey F ^a   Sclar, David A ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CASE CONTROL STUDY; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG EXPOSURE; FEMALE; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STUDY DESIGN; TREATMENT DURATION; CHEMICALLY INDUCED; CLOSTRIDIUM INFECTIONS; CRITICAL ILLNESS; INTENSIVE CARE UNIT; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; RISK FACTOR; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84924273730     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-014-0714-7     Document Type: Article

References (24)

1. Bobo LD, Dubberke ER, Kollef M: Clostridium difficile in the ICU: the struggle continues. Chest 2011, 140:1643-1653.
2. Micek ST, Schramm G, Morrow L, Frazee E, Personett H, Doherty JA, Hampton N, Hoban A, Lieu A, McKenzie M, Dubberke ER, Kollef MH: Clostridium difficile infection: a multicenter study of epidemiology and outcomes in mechanically ventilated patients. Crit Care Med 2013, 41:1968-1975.
3. Barletta JF, El-Ibiary SY, Davis LE, Nguyen B, Raney CR: Proton pump inhibitors and the risk for hospital-acquired clostridium difficile infection. Mayo Clin Proc 2013, 88:1085-1090.
4. Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, Talmor D: Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010, 170:784-790.
5. Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN: Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol 2012, 107:1001-1010.
6. Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK: Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 2012, 107:1011-1019.
7. Leonard J, Marshall JK, Moayyedi P: Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 2007, 102:2047-2056. quiz 2057.
8. Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, Toye B, Beaudoin A, Frost EH, Gilca R, Brassard P, Dendukuri N, Beliveau C, Oughton M, Brukner I, Dascal A: Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011, 365:1693-1703.
9. MacLaren R, Reynolds PM, Allen RR: Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med 2014, 174:564-574.
10. Apte NM, Karnad DR, Medhekar TP, Tilve GH, Morye S, Bhave GG: Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial. Crit Care Med 1992, 20:590-593.
11. Gulmez SE, Holm A, Frederiksen H, Jensen TG, Pedersen C, Hallas J: Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med 2007, 167:950-955.
12. Sarkar M, Hennessy S, Yang YX: Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med 2008, 149:391-398.
13. Barletta JF, Kanji S, MacLaren R, Lat I, Erstad BL: Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada. J Crit Care 2014, 29:955-960.
14. Barletta JF, Lat I, Micek ST, Cohen H, Olsen KM, Haas CE: Off-label use of gastrointestinal medications in the intensive care unit. J Intensive Care Med 2013. [Epub ahead of print]. doi:10.1177/0885066613516574.
15. Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, Mark RG, Mietus JE, Moody GB, Peng CK, Stanley HE: PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation 2000, 101:E215-E220.
16. Saeed M, Villarroel M, Reisner AT, Clifford G, Lehman LW, Moody G, Heldt T, Kyaw TH, Moody B, Mark RG: Multiparameter intelligent monitoring in intensive care II: a public-access intensive care unit database. Crit Care Med 2011, 39:952-960.
17. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER: Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 2009, 301:2120-2128.
18. Ohara T, Arakawa T: Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells. Dig Dis Sci 1999, 44:1710-1715.
19. Yoshida N, Yoshikawa T, Tanaka Y, Fujita N, Kassai K, Naito Y, Kondo M: A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther 2000, 14:74-81.
20. Zedtwitz-Liebenstein K, Wenisch C, Patruta S, Parschalk B, Daxbock F, Graninger W: Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity. Crit Care Med 2002, 30:1118-1122.
21. Beaulieu M, Williamson D, Pichette G, Lachaine J: Risk of Clostridium difficile-associated disease among patients receiving proton-pump inhibitors in a Quebec medical intensive care unit. Infect Control Hosp Epidemiol 2007, 28:1305-1307.
22. Shaughnessy MK, Micielli RL, DePestel DD, Arndt J, Strachan CL, Welch KB, Chenoweth CE: Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 2011, 32:201-206.
23. Jhung MA, Banerjee SN: Administrative coding data and health care-associated infections. Clin Infect Dis 2009, 49:949-955.
24. Goto M, Ohl ME, Schweizer ML, Perencevich EN: Accuracy of administrative code data for the surveillance of healthcare-associated infections: a systematic review and meta-analysis. Clin Infect Dis 2014, 58:688-696.